Advertisement

Cytotechnology

, 59:191 | Cite as

Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration

  • Ying Zhang
  • Hui Zhang
  • Pengfei Yu
  • Qian Liu
  • Kun Liu
  • Huiying Duan
  • Ginling Luan
  • Kazumi Yagasaki
  • Guoying Zhang
JAACT Special Issue

Abstract

The purpose of this study is to investigate in vitro and ex vivo effects of matrine on the growth of human lung cancer and hepatoma cells and the cancer cell migration as well as the expressions of related proteins in the cancer cells. Matrine significantly inhibited the in vitro and ex vivo growth of human non-small cell lung cancer A549 and hepatoma SMMC-7721 cells. Matrine induced the apoptosis in A549 and SMMC-7721 cells. Western blot analysis indicated that matrine dose-dependently down-regulated the expression of anti-apoptotic protein Bcl-2 and up-regulated the level of pro-apoptotic protein bax, eventually leading the reduction of ratios of Bcl-2/Bax proteins in A549 and SMMC-7721 cells. Furthermore, matrine significantly suppressed the A549 cell migration without reducing the cell viability. In addition, matrine dramatically reduced the secretion of vascular endothelial growth factor A in A549 cells. More importantly, matrine markedly enhanced the anticancer activity of anticancer agent trichostatin A (the histone deacetylase inhibitor) by strongly reducing the viability and/or the ratio of Bcl-2/Bax protein in A549 cells. Our findings suggest that matrine may have the broad therapeutic and/or adjuvant therapeutic application in the treatment of human non-small cell lung cancer and hepatoma.

Keywords

Matrine Trichostatin A Non-small cell lung cancer Hepatoma, growth Migration Bcl-2/Bax Vascular endothelial growth factor 

Abbreviations

MA

Matrine

TSA

Trichostatin A

S

Celecoxib

NF-κB

Nuclear factor κB

VEGF-A

Vascular endothelial growth factor A

NSCLC

Non-small cell lung cancer

Notes

Acknowledgments

This work is supported in part by grants from the Ministry of Education of the People’s Republic of China to G. Z, from the Ministry of Human Resources and Social Security of the People’s Republic of China to G. Z, Priority Project Fund of Yantai University to G. Z, and Projects from the Department of Science and Technology of Shandong Province to G. Z. (Y2008C71; 2009GG10002087).

References

  1. Bremnes RM, Camps C, Sirera R (2006) Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer 51:143–158CrossRefGoogle Scholar
  2. Chen Q, Gong B, Mahmoud-Ahmed AS, Zhou A, Hsi ED, Hussein M, Almasan A (2001) Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood 98:2183–2192CrossRefGoogle Scholar
  3. Chen CH, Lai JM, Chou TY, Chen CY, Su LJ, Lee YC, Cheng TS, Hong YR, Chou CK, Whang-Peng J, Wu YC, Huang CY (2009) VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3 K/AKT pathway. PLoS ONE 4:e5052CrossRefGoogle Scholar
  4. Gao G, Law FC (2009) Physiologically based pharmacokinetics of matrine in the rat after oral administration of pure chemical and ACAPHA. Drug Metab Dispos 37:884–891CrossRefGoogle Scholar
  5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71–96CrossRefGoogle Scholar
  6. Lao Y (2005) Clinical study of matrine injection on preventing liver function damage of anti-tumor drugs during chemotherapy of breast cancer. Zhong Yao Cai 28:735–737Google Scholar
  7. Liu XY, Fang H, Yang ZG, Wang XY, Ruan LM, Fang DR, Ding YG, Wang YN, Zhang Y, Jiang XL, Chen HC (2008) Matrine inhibits invasiveness and metastasis of human malignant melanoma cell line A375 in vitro. Int J Dermatol 47:448–456CrossRefGoogle Scholar
  8. Liu B, Peng XC, Zheng XL, Wang J, Qin YW (2009) MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer. doi: 10.1016/j.lungcan.2009.01.010
  9. Luo C, Zhu Y, Jiang T, Lu X, Zhang W, Jing Q, Li J, Pang L, Chen K, Qiu F, Yu X, Yang J, Huang J (2007) Matrine induced gastric cancer MKN45 cells apoptosis via increasing pro-apoptotic molecules of Bcl-2 family. Toxicology 229:245–252CrossRefGoogle Scholar
  10. Ma L, Wen S, Zhan Y, He Y, Liu X, Jiang J (2008) Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells. Planta Med 74:245–251CrossRefGoogle Scholar
  11. Oltvai ZN, Milliman C, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609–619CrossRefGoogle Scholar
  12. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefGoogle Scholar
  13. Wu XL, Hang TJ, Shen JP, Zhang YD (2006) Determination and pharmacokinetic study of oxymatrine and its metabolite matrine in human plasma by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 41:918–924CrossRefGoogle Scholar
  14. Zhang G, Miura Y, Yagasaki K (1999) Effects of green, oolong and black teas and related components on the proliferation and invasion of hepatoma cells in culture. Cytotechnology 31:37–44CrossRefGoogle Scholar
  15. Zhang G, Miura Y, Yagasaki K (2000) Induction of apoptosis and cell cycle arrest in cancer cells by in vivo metabolites of teas. Nutr Cancer 38:265–273CrossRefGoogle Scholar
  16. Zhang G, Miura Y, Yagasaki K (2001) Inhibitory effects of theanine and sera from theanine-fed rats on receptor-mediated cancer cell beneath mesothelial-cell monolayers. Cytotechnology 36:195–200CrossRefGoogle Scholar
  17. Zhang L, Wang T, Wen X, Wei Y, Peng X, Li H, Wei L (2007) Effect of matrine on HeLa cell adhesion and migration. Eur J Pharmacol 563:69–76CrossRefGoogle Scholar
  18. Zhang L, Liu W, Zhang R, Wang Z, Shen Z, Chen X, Bi K (2008) Pharmacokinetic study of matrine, oxymatrine and oxysophocarpine in rat plasma after oral administration of Sophora flavescens Ait. extract by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 47:892–898CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Ying Zhang
    • 1
  • Hui Zhang
    • 2
  • Pengfei Yu
    • 3
  • Qian Liu
    • 3
  • Kun Liu
    • 3
  • Huiying Duan
    • 3
  • Ginling Luan
    • 3
  • Kazumi Yagasaki
    • 4
  • Guoying Zhang
    • 3
  1. 1.Clinical MedicineClinical College of Anhui Medical UniversityHefeiChina
  2. 2.Biological Sciences, Lishan CollegeShandong Normal UniversityJinanChina
  3. 3.Laboratory of Molecular Pharmacology, School of PharmacyYantai UniversityYantaiChina
  4. 4.Department of Applied Biological ScienceTokyo Noko UniversityFuchu, TokyoJapan

Personalised recommendations